Medical
Emergency and critical care applications of interventional radiology (Proceedings)
November 1st 2010Following the trends in human medicine, there is an ongoing effort to adapt and develop minimally invasive therapeutics for the management of various problems facing veterinary patients. Minimally invasive therapeutics offer the advantages of smaller incisions, decreased pain, shortened anesthesia times and shorter length-of-stay compared to traditional open surgical approaches.
Drug-induced liver injury (Proceedings)
November 1st 2010Drug-induced injury is an important cause of hepatic disease in dogs and cats. The incidence of drug-induced hepatic disease is unknown but is probably underestimated. Many drugs have been suspected of causing hepatic injury in dogs and cats. Most adverse hepatic drug reactions are associated with acute hepatic injury.
Diagnostic approach in dogs with increased ALP activity (Proceedings)
November 1st 2010An increase in serum alkaline phosphatase (ALP) activity is a common laboratory finding in dogs. It is typically used as a diagnostic marker for cholestatic liver disease. However, increased ALP activity has a high sensitivity (86%) but poor specificity (49%) for canine liver disease.
Conservative medical management of chronic renal failure in the cat (Proceedings)
November 1st 2010Despite recent technological advances in dialysis and transplantation, conservative medical management remains the most practical and accessible approach to the treatment of chronic renal failure (CRF) for most cat owners and veterinarians.
Practical transfusion medicine for dogs and cats (Proceedings)
November 1st 2010Veterinary transfusion medicine practices have evolved considerably over the last 10 years as we have come to better understand immunology, infectious disease, and the appropriate use of blood and blood products. Some of our biggest advances in ensuring the provision of a safe blood product has come as a result of our errors including, but not limited to acute immunologic transfusion reactions and delayed non-immunologic transfusion reactions (infectious disease transmission).
Assessment and care of the senior cat (Proceedings)
November 1st 2010Whether you call these patients geriatric, or "mature", special considerations are required in evaluating, examining, hospitalizing, and generally caring for older felines. Veterinarians and owners must understand that OLD AGE IS NOT A DISEASE, IT IS A STAGE OF LIFE.
What's new in antiarrhythmic therapy (Proceedings)
November 1st 2010Identification and correction of the underlying causes of arrhythmias are key to their long-term, successful management. For instance, in a cat with atrial standstill as a result of hyperkalemia from urethral obstruction, the arrhythmia is best addressed by correction of the underlying problem, hyperkalemia, as primary antiarrhythmic therapy is generally unsuccessful when such electrolyte abnormalities are present.
Thoracic trauma: keys to success (Proceedings)
November 1st 2010Traumatized small animal patients represent a population in which a standardized approach to diagnosis centered on thorough background knowledge of traumatic injuries coupled with a complete physical examination will allow for rapid therapeutic interventions and optimization of patient care.
Is that mushroom toxic? (Proceedings)
November 1st 2010Human and canine exposure to potentially toxic mushrooms is relatively common. In 2007, the American Association of Poison Control Centers (AAPCC) reported a total of ~ 7700 calls related to mushroom exposure. The difficulty for the clinician is that rapid and proper identification of ingested mushrooms occurs infrequently.
Immunosuppressive drugs: beyond glucocorticoids (Proceedings)
November 1st 2010Glucocorticoids are the most commonly used drugs for immunosuppression of dogs and cats with immune-mediated diseases because they induce rapid, non-specific inhibition of the immune system by reducing inflammation-associated gene transcription, inhibiting intracellular signaling pathways, down-regulating cell membrane expression of adhesion proteins, and slowing cell proliferation.
Nutraceuticals: myth or must? (Proceedings)
November 1st 2010Close to 30% of pet owners have used or considered the use of novel ingredients (eg, nutraceuticals and herbs/botanicals) in their animals. In the USA, approximately 90% of veterinarians sell some type of novel ingredient and the current market of veterinary novel ingredients is between $20 and $50 million per year.
Update on hepatoprotective therapies (Proceedings)
November 1st 2010Hepatoprotective agents are receiving attention for their role in the ancillary treatment of liver disease in dogs and cats. These products include both prescription drugs and dietary supplements (vitamins, minerals, herbs, nutraceuticals). A drug is defined as "any substance, food, or nonfood that is used to treat, cure, mitigate, or prevent a disease and any nonfood substance that is intended to affect the structure or function of man or animals".
Care of the canine and feline neonate: part 1 (Proceedings)
November 1st 2010Puppies and kittens are generally considered to be neonates from birth to two weeks of age although some references consider the neonate period to extend to four weeks of age. Neonates pose special problems in husbandry and health care due to their small size and developing organ systems.
Management of hypokalemia and hyperkaemia (Proceedings)
November 1st 2010Over 90% of the potassium in the body is located within cells. External balance for potassium is maintained by matching output to input. Internal balance is maintained by translocation of potassium between intracellular and extracellular fluid. Any change in plasma potassium concentration must arise from a change in intake, distribution, or excretion.
Do's and don'ts of decontamination (Proceedings)
November 1st 2010A number of factors need to be considered in deciding the best approach to decontaminating a toxicant-exposed patient. In animals orally exposed to toxicants, these factors include consideration of the substance and amount ingested, whether multiple agents were ingested, the time since ingestion, whether attempts at decontamination have been undertaken prior to presentation, the species of animal involved, number of individuals exposed and whether there is any known underlying organ dysfunction, especially affecting the liver or kidneys.
Practical transfusion therapy (Proceedings)
November 1st 2010The transfusion of blood products to treat acute blood losses, coagulopathies, and severe anemia has become indispensable in the care of critically ill veterinary patients. As with any therapy, the risks, cost and potential benefits associated with the use of blood products must be carefully considered and every effort should be made to minimize the occurrence of adverse effects.